CHOLANGIOCARCINOMA

Advertisement
Dec 25 2025HEALTH

Unlocking the Secrets of Cholangiocarcinoma: A New Approach to Finding Biomarkers

Cholangiocarcinoma is a tricky cancer to deal with. It starts in the bile ducts and is not easy to spot early. This makes finding good biomarkers super important. Biomarkers are like signs that can tell doctors if someone might have cancer or how it's doing. Researchers have been looking for these s

reading time less than a minute
Jul 02 2025HEALTH

Can AI Predict How Well Cancer Treatment Will Work?

Cholangiocarcinoma (CCA) is a tough cancer to treat. Doctors have a hard time figuring out which treatments will work best for each patient. One big challenge is predicting how well a patient will respond to immunotherapy, a treatment that helps the body's own immune system fight cancer. Researcher

reading time less than a minute
Mar 22 2025HEALTH

Metabolic Syndrome and Bile Duct Cancer: What's the Link?

The liver is a vital organ. It has many jobs, including filtering blood and producing bile. Bile is important for digesting fats. The bile ducts are tiny tubes that carry bile from the liver to the small intestine. Sometimes, cancer can grow in these ducts. This is called cholangiocarcinoma. It can

reading time less than a minute
Feb 05 2025HEALTH

The Path to Better Treatment: Rethinking Neoadjuvant Therapy for Liver Cancer

Neoadjuvant therapy could be a game-changer in treating liver cancer. It is a type of cancer that starts in the bile ducts inside the liver. These bile ducts are like tiny tubes that help move waste from the liver to the gut. It is often caught late and is hard to treat. Doctors are now looking at

reading time less than a minute
Jan 22 2025HEALTH

Discovering New Ways to Fight Biliary Tract Cancer

Ever wondered why finding new medicines for biliary tract cancer is so hard? It's not just one disease, but a group of different tumors affecting the inside and outside of the liver's bile ducts, and even the gallbladder. Each type has its own genetic make-up, making it a real puzzle for scientists.

reading time less than a minute
Jan 18 2025HEALTH

Pancreatic Tumor Surgery: How Many Lymph Nodes Matter?

Imagine you're having surgery to remove a tumor from your pancreas. Doctors want to know how many nearby lymph nodes to take out. Why? Because it can affect your chances of recovery. In a recent study, doctors looked into the best way to remove lymph nodes during this type of surgery for a specific

reading time less than a minute
Dec 30 2024HEALTH

Cleaning Up Water for Health in Thailand: A New Method to Stop Liver Cancer

Thailand has a problem: not enough places to treat sewage properly. This matters because it lets a tiny parasite called Opisthorchis viverrini (OV) lurk in the water and cause a serious liver cancer called cholangiocarcinoma (CCA). The government tried to fix this by making local governments build w

reading time less than a minute
Dec 25 2024HEALTH

Why Biliary Tract Cancer is Often Caught Late

Biliary tract cancer, or BTC, starts in the bile ducts inside the liver (intrahepatic cholangiocarcinoma), the main ducts near the liver (extrahepatic cholangiocarcinoma), or the gallbladder (gallbladder cancer). Because symptoms are often vague and there are no routine screenings, most patients don

reading time less than a minute
Nov 28 2024HEALTH

The Silent Killer: Liver Cancer in Fish-Eating Villages

In the heart of southern Lao PDR, a silent killer lurks in the form of cholangiocarcinoma (CCA), a deadly liver cancer. This disease is, in part, caused by a tiny parasite called Opisthorchis viverrini (OV). People in high-risk rural communities often eat raw or undercooked river fish, which can car

reading time less than a minute
Nov 08 2024HEALTH

Exploring the Best Dose of Atractylodes lancea for Advanced Liver Cancer

A recent small-scale clinical trial showed that Atractylodes lancea (AL) could help slow down tumor growth and reduce death rates in people with advanced liver cancer. This study looked into figuring out the best dose of AL to use in future trials. The original trial found that doses between 1, 000

reading time less than a minute